FOSTER OCULAR IMMUNOLOGY SOCIETY INC (EIN 582676577) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

ESEN AKPEK

Phone

8166991355

Tax Period

2024-01-01 to 2024-12-31

FOSTER OCULAR IMMUNOLOGY SOCIETY INC, founded in 2003, is a small nonprofit in the Diseases & Disorders sector that reported $409K in total revenue in fiscal year 2024. Revenue grew 16% year-over-year, indicating healthy expansion. Expenses of $394K left a modest 4% surplus.

Mission

THE ORGANIZATION HOSTS DINNERS AND CONFERENCES IN ORDER TO RAISE AWARENESS AND EDUCATE PROFESSIONALS ABOUT VARIOUS ADVANCEMENTS IN THE OCULAR IMMUNIZATION FIELD.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $394,216

Investment Income $14,791

Other Revenue $0

TOTAL REVENUE $409,007

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $377,460

Other Expenses $394,224

TOTAL EXPENSES $394,224

Year-over-Year Comparison

	2024	2023	Change
Revenue	$409,007	$353,040	+0.2%
Expenses	$394,224	$303,353	+0.3%
Net Income	$14,783	$49,687	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$25,461

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ESEN AKPEK	PRESIDENT	1.50	Officer	$0	$0	$0
VIRENDAR SANGWAN	VICE PRESIDE	1.50	Officer	$0	$0	$0
DAVID CHU	PAST PRESIDE	1.50	Officer	$0	$0	$0
ERIK LETKO	TREASURER	1.50	Officer	$0	$0	$0
QUAN DONG NGUYEN	EXECUTIVE VP	1.50	Officer	$0	$0	$0
MAITE SAINZ DE LA MAZA	SECRETARY	1.50	Officer	$0	$0	$0
ELISABETTA MISEROCCHI	SECRETARY	1.50	Officer	$0	$0	$0
SARKIS SOUKIASIAN	PAST PRESIDE	1.50	Officer	$0	$0	$0
BROOKE JONES	EXECUTIVE DI	15.00	Officer	$25,461	$0	$25,461

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$409,007	$394,224	$505,840	$14,783
2023	$353,040	$303,353	$475,627	$49,687
2022	$224,993	$289,729	$399,268	$-64,736
2021	$66,352	$122,590	$518,235	$-56,238
2020	$165,070	$89,065	$580,114	$76,005
2019	$338,128	$280,431	$482,815	$57,697
2018	$261,070	$208,430	$386,450	$52,640

FOSTER OCULAR IMMUNOLOGY SOCIETY INC